Información del producto
- N-(4-Methyl-2-thiazolyl)-2-[(6-phenyl-3-pyridazinyl)thio]-acetamide
VU0240551 is a novel, potent, and selective allosteric modulator of the GABA receptor. It has been shown to have an excitatory effect in animal models of epilepsy and depression. VU0240551 has been shown to act as an allosteric modulator of α5-containing GABAA receptors, but not α1- or α2-containing GABAA receptors. This drug also potently increased chloride transport rates in mouse hippocampal neurons without affecting sodium or potassium transport rates. It has been proposed that this drug may be used for the treatment of seizures, depression, and chronic pain.
VU0240551 is currently being evaluated for its efficacy as a therapeutic agent for the treatment of epilepsy and depression by a Phase 2 clinical trial (NCT02696679).
Propiedades químicas
Consulta técnica sobre: 3D-TKB99034 VU0240551
Si desea solicitar un presupuesto o realizar un pedido, por favor añada los productos deseados a su carrito y solicite un presupuesto o pedido desde el carrito. Es más rápido, más barato, y podrá beneficiarse de los descuentos y las ventajas disponibles.
